<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Withania somnifera modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC&apos;s)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Dhaneshree</forename><surname>Bestinee</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Discipline of Medical Biochemistry</orgName>
								<orgName type="department" key="dep2">Faculty of Health Sciences</orgName>
								<orgName type="institution" key="instit1">Nelson Mandela School of Medicine</orgName>
								<orgName type="institution" key="instit2">University of KwaZulu-Natal</orgName>
								<address>
									<postCode>4013</postCode>
									<settlement>Durban</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anil</forename><forename type="middle">Amichund</forename><surname>Chuturgoon</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Discipline of Medical Biochemistry</orgName>
								<orgName type="department" key="dep2">Faculty of Health Sciences</orgName>
								<orgName type="institution" key="instit1">Nelson Mandela School of Medicine</orgName>
								<orgName type="institution" key="instit2">University of KwaZulu-Natal</orgName>
								<address>
									<postCode>4013</postCode>
									<settlement>Durban</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alisa</forename><surname>Phulukdaree</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Discipline of Medical Biochemistry</orgName>
								<orgName type="department" key="dep2">Faculty of Health Sciences</orgName>
								<orgName type="institution" key="instit1">Nelson Mandela School of Medicine</orgName>
								<orgName type="institution" key="instit2">University of KwaZulu-Natal</orgName>
								<address>
									<postCode>4013</postCode>
									<settlement>Durban</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kanive</forename><surname>Parashiva Guruprasad</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Division of Biotechnology</orgName>
								<orgName type="department" key="dep2">School of Life Sciences</orgName>
								<orgName type="institution">Manipal University</orgName>
								<address>
									<addrLine>Planetarium Complex</addrLine>
									<postCode>576 104</postCode>
									<settlement>Manipal</settlement>
									<region>Karnataka</region>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kapaettu</forename><surname>Satyamoorthy</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Division of Biotechnology</orgName>
								<orgName type="department" key="dep2">School of Life Sciences</orgName>
								<orgName type="institution">Manipal University</orgName>
								<address>
									<addrLine>Planetarium Complex</addrLine>
									<postCode>576 104</postCode>
									<settlement>Manipal</settlement>
									<region>Karnataka</region>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Vikash</forename><surname>Sewram</surname></persName>
							<email>vsewram@sun.ac.za</email>
							<idno type="ORCID">0000-0002-4547-7270</idno>
							<affiliation key="aff0">
								<orgName type="department">African Cancer Institute</orgName>
								<orgName type="institution">Stellenbosch University</orgName>
								<address>
									<postBox>P.O. Box 241</postBox>
									<postCode>8000</postCode>
									<settlement>Cape Town</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Global Health</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health Sciences</orgName>
								<orgName type="institution">Stellenbosch University</orgName>
								<address>
									<postBox>P.O. Box 241</postBox>
									<postCode>8000</postCode>
									<settlement>Cape Town</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">African Cancer Institute</orgName>
								<orgName type="institution">Stellenbosch University</orgName>
								<address>
									<postBox>P.O. Box 241</postBox>
									<postCode>8000</postCode>
									<settlement>Cape Town</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Global Health</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health Sciences</orgName>
								<orgName type="institution">Stellenbosch University</orgName>
								<address>
									<postBox>P.O. Box 241</postBox>
									<postCode>8000</postCode>
									<settlement>Cape Town</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Withania somnifera modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC&apos;s)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">D131E5E457E4EB86FDB31AFFD5289DFE</idno>
					<idno type="DOI">10.1186/s12906-018-2192-y</idno>
					<note type="submission">Received: 2 June 2017 Accepted: 28 March 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:31+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Cancer</term>
					<term>Cachexia</term>
					<term>Cytokines</term>
					<term>Apoptosis</term>
					<term>Withania somnifera</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Cancer and inflammation are associated with cachexia.</s><s>Withania somnifera (W.</s><s>somnifera) possesses antioxidant and anti-inflammatory potential.</s><s>We investigated the potential of an aqueous extract of the root of W. somnifera (W RE ) to modulate cytokines, antioxidants and apoptosis in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC's).</s></p><p><s>Methods: Cytotoxcity of W RE was determined at 24 and 72 h (h).</s><s>Oxidant scavenging activity of W RE was evaluated (2, 2-diphenyl-1 picrylhydrazyl assay).</s><s>Glutathione (GSH) levels, caspase (− 8, − 9, − 3/7) activities and adenosine triphosphate (ATP) levels (Luminometry) were thereafter assayed.</s><s>Tumour necrosis factor-α (TNF-α), interleukin (IL)-6, IL-1β and IL-10 levels were also assessed using enzyme-linked immunosorbant assay.</s></p><p><s>Results: At 24 h, W RE (0.2-0.4 mg/ml) decreased PBMC viability between 20 and 25%, whereas it increased THP-1 viability between 15 and 23% (p &lt; 0.001).</s><s>At 72 h, W RE increased PBMC viability by 27-39% (0.05, 0.4 mg/ml W RE ) whereas decreased THP-1 viability between 9 and 16% (0.05-0.4 mg/ml W RE ) (p &lt; 0.001).</s><s>Oxidant scavenging activity was increased by W RE (0.05-0.4 mg/ml, p &lt; 0.0001).</s><s>PBMC TNF-α and IL-10 levels were decreased by 0.2-0.4</s><s>mg/ml W RE, whereas IL-1β levels were increased by 0.05-0.4</s><s>mg/ml W RE (p &lt; 0.0001).</s><s>In THP-1 cells, W RE (0.05-0.4 mg/ml) decreased TNF-α, IL-1β and IL-6 levels (p &lt; 0.0001).</s><s>At 24 h, GSH levels were decreased in PBMC's, whilst increased in THP-1 cells by 0.2-0.4</s><s>mg/ml W RE (p &lt; 0.0001).</s><s>At 72 h, W RE (0.1-0.4 mg/ml) decreased GSH levels in both cell lines (p &lt; 0.0001).</s><s>At 24 h, W RE (0.2-0.4 mg/ml) increased PBMC caspase (-8, -3/7) activities whereas W RE (0.05, 0.1, 0.4 mg/ml) increased THP-1 caspase (-9, -3/7) activities (p &lt; 0.0001).</s><s>At 72 h, PBMC caspase (-8, -9, -3/7) activities were increased at 0.05-0.1 mg/ml W RE (p &lt; 0.0001).</s><s>In THP-1 cells, caspase (-8, -9, -3/7) activities and ATP levels were increased by 0.1-0.2</s><s>mg/ml W RE, whereas decreased by 0.05 and 0.4 mg/ml W RE (72 h, p &lt; 0.0001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion:</head><p><s>In PBMC's and THP-1 cells, W RE proved to effectively modulate antioxidant activity, inflammatory cytokines and cell death.</s><s>In THP-1 cells, W RE decreased pro-inflammatory cytokine levels, which may alleviate cancer cachexia and excessive leukaemic cell growth.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Chronic inflammation plays an essential role in malignancies <ref type="bibr" target="#b0">[1]</ref> through the initiation, promotion and progression of tumours <ref type="bibr" target="#b1">[2]</ref>.</s><s>Usually, the host-mediated anti-tumour activity overcomes the tumour-mediated immunosuppressive activity leading to the elimination of cancerous cells <ref type="bibr" target="#b1">[2]</ref>.</s><s>However, in the presence of an inadequate host antitumour defence, the pro-inflammatory tumour microenvironment is enhanced and promotes tumour development, invasion, angiogenesis and metastasis <ref type="bibr" target="#b1">[2]</ref>.</s></p><p><s>The cachectic syndrome is prominent in malignancies occurring in up to 50% of all cancer patients <ref type="bibr" target="#b2">[3]</ref>.</s><s>It is a progressive, debilitating condition leading to abnormal weight loss, as a result of adipose tissue (85%) and skeletal muscle (75%) depletion <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>.</s><s>Modulation of lipogenesis and lipolysis is essential in maintaining adipose tissue mass.</s><s>Lipoprotein lipase (LPL) hydrolyses fatty acids (FA's) from plasma lipoproteins, thereafter FA's are transported to adipose tissue for triacylglycerol (TAG) production, whereas hormone sensitive lipase (HSL) hydrolyses TAG's into FA's and glycerol <ref type="bibr" target="#b2">[3]</ref>.</s><s>Literature shows that decreased serum LPL levels/activity and increased HSL levels/activity are associated with cachexia <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>.</s><s>Additionally, increased proteolysis <ref type="bibr" target="#b8">[9]</ref> and decreased proteogenesis has been established in cachectic patients <ref type="bibr" target="#b9">[10]</ref>.</s><s>The ATP-ubiquitin-dependent proteolytic pathway has been shown to be responsible for the accelerated proteolysis seen in a variety of wasting conditions, including cancer cachexia <ref type="bibr" target="#b10">[11]</ref>.</s></p><p><s>Inflammatory cytokines, oxidative stress and apoptosis have been implicated in the initiation and progression of cancer, imbalance of catabolic/anabolic processes <ref type="bibr" target="#b11">[12]</ref> and development of cachexia <ref type="bibr" target="#b12">[13]</ref>.</s><s>Production of inflammatory cytokines [tumour necrosis factor-α (TNF-α), interleukin (IL) -6, and IL-1β] is activated by lipopolysaccharide (LPS) that potently stimulates macrophages <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s>The LPS signal is transduced by LPS binding to LPS binding protein, delivered to CD14 and transferred to Toll like receptor-4 <ref type="bibr" target="#b15">[16]</ref>.</s><s>Nuclear factor kappa B (NF-κB) is subsequently activated and regulates the transcription of genes associated with inflammation, proliferation, invasion, angiogenesis and apoptosis <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr">[18]</ref><ref type="bibr" target="#b18">[19]</ref>.</s><s>Proinflammatory cytokines (TNF-α, IL-6 and IL-1) have been shown to decrease LPL activity <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref>, which reduces the uptake of exogenous lipids by adipose tissue <ref type="bibr" target="#b20">[21]</ref>, ultimately decreasing lipogenesis.</s><s>Additionally, previous studies have indicated that TNF-α increased ubiquitin (concentrations and mRNA), while IL-6 increased the 26S proteasome and cathepsins activities, which may activate proteolytic pathways <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref>, ultimately increasing proteolysis.</s><s>In combination, excessive levels of pro-inflammatory cytokines increase tumour suppressive activity <ref type="bibr" target="#b1">[2]</ref> and tissue wasting <ref type="bibr" target="#b2">[3]</ref>.</s></p><p><s>Reactive oxygen species (ROS) have been associated with tumour initiation, inflammation <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b26">27]</ref> and muscle wasting <ref type="bibr" target="#b27">[28]</ref>.</s><s>However, antioxidants have been shown to decrease muscle wasting by neutralizing ROS <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b27">28]</ref>.</s><s>Elevated ROS levels activate apoptotic pathways, ultimately activating caspase-3 <ref type="bibr" target="#b28">[29]</ref>.</s><s>Caspase-3 activation plays an essential role in the execution of apoptosis, as well as muscle proteolysis <ref type="bibr" target="#b29">[30]</ref>.</s><s>In addition, in weight losing upper gastro-intestinal tract cancer patients, deoxyribonucleic acid (DNA) fragmentation and poly (ADP-ribose) polymerase (PARP) cleavage were increased, whereas MyoD protein was decreased, indicating increased apoptosis and decreased muscle replenishment <ref type="bibr" target="#b2">[3]</ref>.</s></p><p><s>Cancer patients suffer from a wide range of side-effects caused by current cancer chemotherapeutic and radiotherapeutic agents.</s><s>Patients are constantly seeking alternative traditional remedies to alleviate their discomfort.</s><s>Withania somnifera (L.) Dunal (W.</s><s>somnifera) is a well known medicinal plant cultivated in India, parts of East Asia and Africa <ref type="bibr" target="#b30">[31]</ref>.</s><s>It is commonly referred to as Ashwagandha and belongs to the Solanaceae family <ref type="bibr" target="#b30">[31]</ref>.</s><s>Compounds isolated from W. somnifera include withaferin A and 3-β-hydroxy-2, 3 dihydro withanolide F <ref type="bibr" target="#b31">[32]</ref>.</s><s>The major constituent of the root extract of W. somnifera is withanolide-A <ref type="bibr" target="#b32">[33]</ref>.</s><s>W. somnifera is frequently used in Ayurvedic medicine due to its various medicinal properties <ref type="bibr" target="#b30">[31]</ref>.</s><s>These properties include anti-inflammatory <ref type="bibr" target="#b33">[34]</ref>, antioxidant and immunemodulatory activities <ref type="bibr" target="#b34">[35]</ref>.</s><s>W. somnifera was found to be an immune regulator in inflammation animal models <ref type="bibr" target="#b35">[36]</ref>.</s><s>The immunosuppressive action of W. somnifera may be due to the presence of withanolides, steroidal lactones and a few flavanoids <ref type="bibr" target="#b36">[37]</ref>.</s><s>In addition, W. somnifera formulation (WSF) has shown anti-proliferative potential in human promyelocytic leukemia (HL-60) cells, by activating the intrinsic and extrinsic apoptotic pathways <ref type="bibr" target="#b37">[38]</ref>.</s><s>When used together, W. somnifera formulations aid the host to effectively fight cancer and reduce the harmful effects of chemotherapy and radiotherapy <ref type="bibr" target="#b38">[39]</ref>.</s></p><p><s>There is a need for the discovery of an inexpensive cancer cachectic treatment to improve the prognosis of cancer patients and to establish a mechanism of regulation of the immune system, inflammasome and apoptosis in order to prevent/decelerate the rapid depletion of skeletal muscle and adipose tissue.</s><s>We investigated the effect of an aqueous extract of the root of W. somnifera (W RE ) on antioxidant capacity, inflammatory cytokine levels and cell death induction in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC's).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials</head><p><s>The roots of W. somnifera were collected on the 11th of March 2011 (collectors number: Immelman 427) from the Eastern Cape [the Ntubeni Location near Dwesa Reserve], South Africa (SA) and identified by Dr. Kathleen Immelman from the Department of Botany at the Walter Sisulu University, SA and further comparison to South African data <ref type="bibr" target="#b39">[40]</ref>.</s><s>Voucher specimens were deposited at the KEI herbarium (13995).</s><s>THP-1 cells were obtained from from American Type Culture Collection (ATCC, University Boulevard Manassas, Virginia, USA).</s><s>RPMI-1640 and BD OptEIA enzyme-linked immunosorbant assay (ELISA) cytokine kits were purchased from The Scientific Group (Johannesburg, SA).</s><s>Foetal calf serum (FCS) and Pen/ Strep Amphotericin B (PSF) were acquired from Whitehead Scientific (Cape Town, SA).</s><s>Dimethyl sulphoxide (DMSO) was purchased from Merck (Johannesburg, SA).</s><s>Histopaque-1077, LPS and 2, 2-diphenyl-1 picrylhydrazyl (DPPH) were purchased from Sigma (Aston Manor, SA).</s><s>The 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulphonate (WST-1) cell proliferation reagent was purchased from Roche (Johannesburg, SA).</s><s>Promega (Madison, USA) supplied the caspase (-3/7, -8, -9), adenosine triphosphate (ATP) and glutathione (GSH) kits.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plant extraction</head><p><s>The roots of W. somnifera were dried and milled before being sequentially extracted in ethanol and distilled water.</s><s>Ethanol (200-350 ml) was added to the milled root (10-30 g) and extracted overnight by shaking (4×g, 37 °C).</s><s>The ethanol extracts were thereafter filtered, evaporated using a rotary evaporator, dried (37 °C) and stored (4 °C).</s><s>The root material was thereafter extracted with distilled water (200-350 ml) by shaking (4×g, 75 °C) for a period of 6 hours (h).</s><s>Water extracts were filtered, dried and stored (4 °C).</s></p><p><s>The 2, 2-diphenyl-1 picrylhydrazyl assay W RE (0.05-0.4 mg/ml) and butylated hydroxytoluene (BHT) (60-300 μM) dilutions were prepared in methanol (99.5% and grade AR).</s><s>A 50 μM DPPH solution was prepared from a stock solution of 0.135 mM DPPH in methanol.</s><s>W RE , BHT dilutions and methanol (1 ml) were aliquoted into 15 ml polypropylene tubes, followed by the 50 μM DPPH solution (1 ml).</s><s>Reaction mixtures were vortexed and incubated [room temperature (RT), 30 min (min)] in the dark.</s><s>Absorbance of samples was read at 517 nm using a Varine Cary 50 UV-visible spectrophotometer (McKinley Scientific, New Jersey, US).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation of peripheral blood mononuclear cells</head><p><s>Buffy coats containing PBMC's were obtained from the South African National Blood Service (2011/09).</s><s>PBMC's were extracted by differential centrifugation.</s><s>Buffy coats (5 ml) were layered onto equivolume histopaque-1077 (5 ml) in 15 ml polypropylene tubes and centrifuged (400×g, 21 °C for 30 min).</s><s>After centrifugation, the PBMC's were transferred to sterile 15 ml polypropylene tubes, phosphate buffered saline (PBS) was added (0.1 M, 10 ml) and tubes were centrifuged (400×g, 21 °C, 15 min).</s><s>Cell density of isolated PBMC's was adjusted (1 × 10 6 cells/ml) using the trypan blue exclusion test and cryo-preserved (10% FCS, 10% DMSO) using a NELGENE cryo freezing container and stored at -80 °C.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Tissue culture</head><p><s>THP-1 cells were grown in the appropriate tissue culture conditions in a 75 cm 3 tissue culture flask (37 °C, 5% CO 2 ).</s><s>The growth media comprised of RPMI-1640, FCS (10%) and PSF (2%).</s><s>Cells were thawed, seeded into a 75 cm 3 tissue culture flask at a concentration of 3 × 10 5 cells/ml and incubated (37 °C, 5% CO 2 ).</s><s>THP-1 cells were allowed to grow for 2-3 days before the cells were centrifuged (162×g, 10 min) and re-suspended in fresh growth media.</s><s>The number of cells should not exceed 8 × 10 5 cells/ml, therefore the cells/ml was quantified daily by trypan blue staining.</s><s>Once the cell count reached 8 × 10 5 cells/ml the THP-1 cells were split/diluted to 3 × 10 5 cells/ml with media and incubated.</s><s>Subsequent experiments were conducted once the cell numbers were sufficient.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell viability assay</head><p><s>Cytotoxicity of W RE in PBMC's and THP-1 cells was measured using the WST-1 assay (Roche, Johannesburg, SA).</s><s>PBMC and THP-1 cells (10,000 cells/well, 96-well plate, in triplicate wells) were stimulated with LPS (20 μg/ml, 37 °C, 5% CO 2 , 4 h) before exposure to W RE (0.05-0.4 mg/ml) for 24 and 72 h (37 °C, 5% CO 2 ).</s><s>Similarly, controls received media.</s><s>Thereafter, plates were centrifuged (162×g, 10 min), supernatant removed, cell pellets re-suspended in growth media (100 μl/well), WST-1 reagent (10 μl/well) added and plates incubated (37 °C, 5%, CO 2 , 3 h).</s><s>Optical density was measured at 450 nm (620 nm reference wavelength) with a BIO-TEK μQuant spectrophotometer (Analytical and Diagnostic Products, SA).</s><s>This experiment was conducted independently on three occasions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Stimulation and treatment of cells</head><p><s>PBMC's and THP-1 cells (1 × 10 5 cells/ml) were transferred into 24-well plates and stimulated with LPS (20 μg/ml, 37 °C, 5% CO 2 , 4 h) before exposure to W RE (0.05-0. 4 mg/ml) for 24 h (TNF-α) and 72 h (IL-1β, IL-6, IL-10) (37 °C, 5% CO 2 ).</s><s>After incubation, plates were centrifuged (162×g, 10 min) and the supernatant collected and stored (− 80 °C) for cytokine analysis.</s><s>Cell pellets were used to conduct the caspase (-8, -9, -3/7) activity, as well as ATP and GSH assays.</s><s>The experiments were conducted independently (twice) for all subsequent assays.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantification of cytokines</head><p><s>Cytokine levels were estimated using the BD OptEIA ELISA kits (The Scientific Group, SA) and the procedure was followed as per the instruction manual.</s><s>ELISA plates were coated with capture antibody overnight (100 μl/ well, 4 °C).</s><s>Thereafter, plates were washed (3×) with wash buffer and blocked with assay diluent (200 μl/well, 1 h, RT).</s><s>Standard solutions were prepared by diluting a stock solution [TNF-α, IL-10 (500 pg/ml), IL-6 (300 pg/ml) , IL-1β (250 pg/ml)] serially [TNF-α, IL-10 (500-7.8</s><s>pg/ml), IL-6 (300-4.7 pg/ml), IL-1β (250-3.9</s><s>pg/ml)].</s><s>Plates were washed (3×), standards and samples (100 μl/well) were aliquoted into appropriate wells and plates were incubated (2 h, RT).</s><s>Plates were washed (5×), working detector (100 μl/well) added and plates incubated (1 h, RT).</s><s>The plates were washed (7×), substrate solution (100 μl/well) added and plates were incubated (30 min, RT) in the dark.</s><s>Finally, stop solution (50 μl/well) was added and the absorbance was read at 450 nm (570 nm reference wavelength) with a Multiskan FC micro-plate reader (Thermo Scientific).</s><s>Cytokine concentrations were calculated by extrapolation from a standard curve.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The glutathione assay</head><p><s>The GSH-Glo™ assay (Promega, Madison, USA) was performed to measure GSH levels.</s><s>Standard GSH solutions were prepared by diluting a 5 mM stock solution serially (1.56-50 μM) and PBS (0.1 M) was the standard blank.</s><s>Cells (50 μl/well, 2 × 10 5 cells/ml) and standards were added into an opaque 96-well plate, followed by GSH-Glo™ reagent (25 μl/well) and allowed to incubate (30 min, RT) in the dark.</s><s>Luciferin detection reagent (50 μl/well) was subsequently added and plates incubated (15 min, RT) in the dark.</s><s>The absorbance was read on a Modulus™ microplate luminometer (Turner Biosystems, Sunnyvale, USA) and GSH concentrations were calculated by extrapolation from a standard curve.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Caspase and ATP assays</head><p><s>Caspase activity and ATP levels were determined using the Caspase-Glo®-3/7, -8, -9 and ATP assay kits (Promega, Madison, USA).</s><s>Caspase-Glo®-3/7, -8, -9 and ATP reagents were reconstituted according to the manufacturer's instructions.</s><s>Cells (100 μl, 2 × 10 5 cells/ml) were added into duplicate wells of a microtitre plate for each assay, thereafter caspase -3/7, -8, -9 and ATP reagents (100 μl/ well) were added into appropriate wells.</s><s>The plate was incubated (30 min, RT) in the dark.</s><s>Luminescence was measured on a Modulus™ microplate luminometer (Turner BioSystems) and expressed as relative light units (RLU).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical analysis was performed using the STATA and GraphPad Prism statistical analysis software.</s><s>The one-way analysis of variance (ANOVA) was used to compare between groups, followed by the Tukey multiple comparisons test, with p &lt; 0.05 defining statistical significance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>The oxidant scavenging potential of W RE</s></p><p><s>The oxidant scavenging activity of W RE using the DPPH assay is shown in Fig. <ref type="figure" target="#fig_0">1</ref>.</s><s>W RE (0.05-0.4 mg/ml) significantly increased DPPH scavenging activity by 13.33-46.</s><s>38% (Fig. <ref type="figure" target="#fig_0">1</ref>, p &lt; 0.0001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The in vitro cytotoxicity of W RE</head><p><s>The WST-1 assay was used to determine cell viability of THP-1 cells and PBMC's after treatment with W RE (Fig. <ref type="figure" target="#fig_1">2</ref>).</s><s>At 24 h, W RE (0.05-0.4 mg/ml) decreased PBMC viability by 20.69-25.15%</s><s>while W RE (0.2-0.4 mg/ml) increased THP-1 viability by 15.99-22.54%</s><s>as compared to the controls (Fig. <ref type="figure" target="#fig_1">2a and c</ref>, p &lt; 0.001).</s><s>This result suggests that PBMC's are more sensitive to W RE treatment than THP-1 cells.</s></p><p><s>At 72 h, PBMC viability was increased (27.16-38.58%)</s><s>by W RE (0.05, 0.4 mg/ml) , as compared to the control (Fig. <ref type="figure" target="#fig_1">2b</ref>, p &lt; 0.0001).</s><s>In the same time period, W RE (0. 05-0.4 mg/ml) decreased THP-1 viability by 9.07-16.</s><s>09% relative to the control (Fig. <ref type="figure" target="#fig_1">2d</ref>, p=0.0002).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The immune suppressive properties of W RE</head><p><s>W RE altered cytokine levels in PBMC's and THP-1 cells (Fig. <ref type="figure" target="#fig_2">3</ref> and Fig. <ref type="figure" target="#fig_3">4</ref>).</s><s>The levels of TNF-α, IL-1β, IL-6 and IL-10 produced by LPS stimulated PBMC's was 336.218, 168.100, 657.878 and 46.990 pg/ml respectively.</s><s>W RE (0.2-0.4 mg/ ml) decreased PBMC TNF-α and IL-10 levels as compared to the control (Fig. <ref type="figure" target="#fig_2">3a and d</ref>, p &lt; 0.0001).</s><s>In PBMC's, IL-6 levels were decreased by 0.4 mg/ml W RE, whereas IL-1β levels were increased by 0.05-0.</s><s>4 mg/ml W RE relative to the control (Fig. <ref type="figure" target="#fig_2">3b and c</ref>, p &lt; 0.0001).</s><s>The levels of TNF-α, IL-1β, IL-6 and IL-10 produced by LPS stimulated THP-1 cells were 13.285, 21.947, 78.622 and 2.705 pg/ml respectively.</s><s>In THP-1 cells, TNF-α, IL-1β and IL-6 levels were decreased by 0.05-0.4</s><s>mg/ml W RE, whilst IL-10 levels were decreased by 0.4 mg/ml W RE as compared to the control (Fig. <ref type="figure" target="#fig_3">4</ref>, p &lt; 0.003).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The antioxidant potential of W RE</head><p><s>The endogenous antioxidant activity of W RE was determined by measuring GSH levels in both cell lines (Table <ref type="table" target="#tab_0">1</ref>).</s><s>At 24 h, GSH levels in PBMC's were decreased by W RE (0.05, 0.2, 0.4 mg/ml) relative to the control (Table <ref type="table" target="#tab_0">1</ref>, p &lt; 0.0001).</s><s>In THP-1 cells, GSH levels were decreased at 0.05 mg/ml W RE whereas increased (0.41-1.62 μM) at 0.1-0.4</s><s>mg/ml W RE compared to the control (Tables 1, 24 h, p &lt; 0.0001).</s></p><p><s>At 72 h, PBMC GSH levels were increased at 0.05 mg/ml whereas decreased 0.1-0.4</s><s>mg/ml W RE compared to the control (Table <ref type="table" target="#tab_0">1</ref>, p &lt; 0.0001).</s><s>W RE (0.05-0.4 mg/ml) decreased GSH levels in THP-1 cells relative to the control (Tables 1, 72 h p &lt; 0.0001).</s></p><p><s>W RE modulates caspase (-8, -9, -3/7) activities and ATP levels Luminometry assays were used to determine caspase activity and ATP levels in THP-1 cells and PBMC's after treatment with W RE .</s><s>The pro-apoptotic effect of W RE in PBMC's treated for 24 h is shown in Table <ref type="table" target="#tab_1">2</ref>.</s><s>At 24 h, PBMC caspase-8 activity was decreased by 0.05 mg/ml W RE whereas increased by 0.2-0.4</s><s>mg/ml W RE compared to the control (Table <ref type="table" target="#tab_1">2</ref>, p &lt; 0.0001).</s><s>PBMC caspase-9 activity was increased by 0.05 and 0.2 mg/ml W RE but decreased by 0.1 and 0.4 mg/ml W RE relative to the control (Table <ref type="table" target="#tab_1">2</ref>, p &lt; 0.0001).</s><s>In PBMC's, the increased caspase activity may be related to the decreased GSH levels at 24 h.</s><s>A decrease in GSH levels may allow for an increase in ROS levels which can activate apoptotic pathways.</s><s>Caspase-3/7 activity was increased in PBMC's by 0.05-0.</s><s>4 mg/ml W RE compared to the control (Table <ref type="table" target="#tab_1">2</ref>, p &lt; 0. 0001), suggesting an increased execution of apoptotic cell death.</s><s>In azoxymethane-induced colon cancer in mice, W. somnifera has been shown to modulate TCA cycle enzymes and the electron transport chain <ref type="bibr" target="#b40">[41]</ref>.</s><s>The PBMC ATP levels were increased by 0.1, 0.4 mg/ml W RE but decreased by 0.05, 0.2 mg/ml W RE compared to the control (Table <ref type="table" target="#tab_1">2</ref>, p &lt; 0.0001), which may be related to the modulation of the electron transport chain by W. somnifera.</s><s>W RE pro-apoptotic effects in THP-1 cells treated for 24 h are shown in Table <ref type="table" target="#tab_2">3</ref>.</s><s>At 24 h, THP-1 caspase-9 activity was decreased by 0.2 mg/ml W RE but increased by 0. 05, 0.1, 0.4 mg/ml W RE compared to the control (Table <ref type="table" target="#tab_2">3</ref>, p &lt; 0.0001).</s><s>At 0.2 mg/ml W RE , the decreased caspase-9 activity may be related to the increased GSH levels.</s><s>An increase in GSH levels may decrease ROS levels thus minimising mitochondrial depolarisation and the activation of the intrinsic apoptotic pathway.</s><s>In THP-1 cells, W RE (0.05-0.4 mg/ml) decreased caspase-8 activity, whereas increased caspase-3/7 activity and ATP levels relative to the control (Table <ref type="table" target="#tab_2">3</ref>, p &lt; 0.0001).</s><s>Elevated caspase (-9, -3/7) activities suggests the initiation of the mitochondrial apoptotic pathway.</s></p><p><s>The pro-apoptotic effect of W RE in PBMC's treated for 72 h is shown in Table <ref type="table" target="#tab_4">4</ref>.</s><s>At 72 h, PBMC caspase-8 activity was increased by 0.05-0.2</s><s>mg/ml W RE but decreased by 0.4 mg/ml W RE compared to the control (Table <ref type="table" target="#tab_4">4</ref>, p &lt; 0.0001).</s><s>PBMC caspase-9 activity was increased by 0.05-0.1 mg/ml W RE but decreased by 0.2-0.</s><s>4 mg/ml W RE relative to the control (Table <ref type="table" target="#tab_4">4</ref>, p &lt; 0. 0001).</s><s>In PBMC's, caspase-3/7 activity was increased by 0.05, 0.1, 0.4 mg/ml W RE whereas it decreased by 0. 2 mg/ml W RE compared to the control (Table <ref type="table" target="#tab_4">4</ref>, p &lt; 0. 0001).</s><s>At 0.05-0.1 mg/ml W RE , the increased caspase-3/ 7 activity is consistent with the significantly increased caspase -8 and -9 activity.</s><s>At 0.2 mg/ml W RE , caspase-8 activity was minimally increased and caspase-9 activity significantly decreased which lead to the decreased caspase-3/7 activity.</s><s>At 0.4 mg/ml W RE , although both caspase -8 and -9 activities were decreased, caspase-3/7 activity was increased.</s><s>A previous study has demonstrated that one activated executioner caspase can cleave and activate other executioner caspases resulting in positive feedback loop of caspase activation <ref type="bibr" target="#b41">[42]</ref> which may account for the increased caspase-3/7 activity at 0.4 mg/ml W RE .</s><s>W RE (0.05-0. 4 mg/ml) decreased PBMC ATP levels relative to the control (Table <ref type="table" target="#tab_4">4</ref>, p &lt; 0.0001).</s><s>W RE pro-apoptotic effects in THP-1 cells treated for 72 h are shown in Table <ref type="table" target="#tab_3">5</ref>.</s><s>At 72 h, THP-1 caspase (-8, -9, -3/7) activity and ATP levels were increased by 0.1-0. 2 mg/ml W RE as compared to the control (Table <ref type="table" target="#tab_3">5</ref>, p &lt; 0. 0001), suggesting an increase in THP-1 apoptotic cell death.</s><s>THP-1 caspase (-8, -9, -3/7) activity and ATP levels were decreased by 0.05, 0.4 mg/ml W RE relative to the control (Table <ref type="table" target="#tab_3">5</ref>, 72 h, p &lt; 0.0001), suggesting a decrease in THP-1 apoptosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Cachexia patients experience excessive weight loss due to increased lipolysis and proteolysis which have been linked to elevated levels of pro-inflammatory cytokines, oxidative stress and apoptosis <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b29">30]</ref>.</s><s>Previously, the powdered root of W. somnifera displayed immune modulatory properties <ref type="bibr" target="#b42">[43]</ref> and WSF has been shown to increase caspase-3 activity, subsequently inducing apoptosis <ref type="bibr" target="#b37">[38]</ref>.</s><s>The objective of this study was thus to investigate the modulation of cytokines, antioxidants and cell death by W RE in PBMC's and THP-1 cells.</s><s><ref type="bibr" target="#b43">Dhanani et al. (2017)</ref> showed that the root extract of W. somnifera inhibited 50% of DPPH at a concentration of 0.4 mg/ml <ref type="bibr" target="#b43">[44]</ref>.</s><s>Our results indicated that W RE has oxidant scavenging potential ranging between 13 and 46% at 0.05-0.4</s><s>mg/ml.</s><s>ROS plays an essential role in tumour initiation, inflammation, protein degradation and apoptosis.</s><s>The antioxidant potential of W RE may decrease inflammatory cytokine levels as well as ROS induced apoptosis.</s></p><p><s>At 24 h, the WST-1 results indicated that W RE decreased PBMC viability whilst increasing THP-1 viability.</s><s>However at 72 h, W RE increased PBMC viability whilst conversely decreasing THP-1 viability.</s><s>In contrast, the growth of various cell lines (HT-29, HCT-15, SW620, 502,713, Colo-205, A549, HOP-62 and Hep-G2) were dose dependently inhibited by WSF and 50% cell growth inhibition was seen at 30 μg/ml WSF <ref type="bibr" target="#b37">[38]</ref>.</s><s>The pivotal role of inflammatory cytokines in malignancies and cachexia has been extensively documented <ref type="bibr" target="#b2">[3]</ref>.</s><s><ref type="bibr" target="#b44">Dhuley (1997)</ref> previously reported that W. somnifera inhibits macrophage production of inflammatory cytokines (IL-1, TNF-α) <ref type="bibr" target="#b44">[45]</ref>.</s><s>Our results showed that W RE decreased PBMC TNF-α, IL-10 and IL-6 levels, although it increased IL-1β levels.</s><s>In THP-1 cells, pro-inflammatory cytokine (TNF-α, IL-1β, IL-6) levels were significantly decreased by W RE .</s></p><p><s>Pro-inflammatory cytokines, over a longstanding time period, stimulate the production of genotoxic molecules [nitric oxide (NO), ROS] and tumour progression by promoting angiogenesis and metastasis <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>In addition, pro-inflammatory cytokines activate NF-κB which regulates the expression of genes involved in the suppression of tumour apoptosis, stimulation of tumour cell cycle progression and enhancement of inflammatory mediators <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>NF-κB promotes tumour progression, invasion, angiogenesis and metastasis <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s></p><p><s>Previous literature has shown that IL-1 stimulates growth and invasion of malignant cells <ref type="bibr" target="#b1">[2]</ref>.</s><s>Additionally, IL-6 has been shown to target cell cycle progression and anti-apoptotic genes leading to tumour proliferation and anti-apoptotic potential <ref type="bibr" target="#b1">[2]</ref>.</s><s>The ability of W RE to increase pro-inflammatory cytokines such as IL-1β in PBMC's may aid in cancerous cell elimination through increased host anti-tumour activity.</s><s>Conversely, in THP-1 cells, the decrease in TNF-α, IL-6 and IL-1β levels by W RE may prevent excessive activation of NF-κB, diminish cytokine induced tumour immunosuppressive activity and cancer progression.</s></p><p><s>With regard to cancer cachexia, IL-6 decreased LPL activity in adipose tissue of mice <ref type="bibr" target="#b21">[22]</ref> and IL-1 directly modulates lipid metabolism by suppressing LPL activity <ref type="bibr" target="#b22">[23]</ref>.</s><s>TNF-α decreased LPL activity in adipose tissue of human (maintained in organ culture), rat, mouse, and guinea pigs <ref type="bibr" target="#b20">[21]</ref>.</s><s>Additionally, TNF-α inhibits the production of LPL and reduces the rate of LPL gene transcription in mouse 3 T3-L1 adipocytes, hence preventing the formation of new lipid stores while stimulating HSL and increasing lipolysis <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b45">46]</ref>.</s><s>The potential of W RE to decrease proinflammatory cytokine levels in PBMC's and THP-1 cells suggests a decrease in LPL inhibition and HSL stimulation, thus maintaining lipogenesis and minimizing lipolysis.</s><s>IL-6 and TNF-α further contribute to cachexia by stimulating muscle catabolism via the activation of proteasome pathways <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b46">47]</ref>.</s><s>In cachexia, NF-κB activation induces ubiquitin-proteasome pathway activity and suppresses MyoD expression <ref type="bibr" target="#b47">[48]</ref>, thereby increasing proteolysis and reducing muscle replenishment <ref type="bibr" target="#b48">[49]</ref>.</s><s>By decreasing TNF-α and IL-6 levels in PBMC's and THP-1 cells, W RE may prevent excessive activation of NF-κB and proteasome pathways, ultimately decreasing proteolysis associated with the cachectic syndrome.</s><s>Taken together, W RE may be able to decrease tissue wasting through the down regulation of pro-inflammatory cytokine levels.</s></p><p><s>The immunosuppressive and anti-inflammatory cytokine, IL-10, inhibits tumour development, tumour progression, modulates apoptosis and suppresses angiogenesis during tumour regression <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>Additionally, IL-10 inhibits NF-κB activation and subsequently inhibits pro-inflammatory cytokine production (TNF-α, and IL-6) <ref type="bibr" target="#b1">[2]</ref>.</s><s>In PBMC's and  THP-1 cells, the decreased IL-10 levels may be due to IL-10 combating increased pro-inflammatory cytokines levels (TNF-α, IL-6, IL-1β).</s></p><p><s>Antioxidants protect cells from increased oxidative stress <ref type="bibr" target="#b49">[50]</ref>.</s><s>GSH is a potent antioxidant that effectively scavenges ROS both directly and indirectly <ref type="bibr" target="#b49">[50]</ref>.</s><s>W. somnifera has previously been shown to possess chemo-preventive activity which may be a consequence of its antioxidant capacity <ref type="bibr" target="#b38">[39]</ref>.</s><s>The 24 h results showed that W RE decreased GSH levels in PBMC's, whereas it increased GSH levels in THP-1 cells.</s><s>However, at 72 h, W RE decreased GSH levels in both cell lines.</s><s>Notably, GSH levels (72 h) were higher in control PBMC's (4.79 μM) compared to control THP-1 cells (1.61 μM), suggesting a higher oxidant defence in PBMC's.</s></p><p><s>The extrinsic (death receptors) and intrinsic (mitochondria) pathways are the two main apoptotic pathways <ref type="bibr" target="#b28">[29]</ref>.</s><s>Activation of initiator caspases (-8, -9) leads to the activation of executioner caspases (-3/7) resulting in activation of cytoplasmic endonucleases <ref type="bibr" target="#b28">[29]</ref>.</s><s>In HL-60 cells, WSF treatment led to a loss of mitochondrial membrane potential, translocation of Bax to mitochondria, release of cytochrome c, Smac/DIABLO and apoptosis inducing factor, suggesting the activation of the intrinsic apoptotic pathway <ref type="bibr" target="#b37">[38]</ref>.</s><s>Additionally, WSF treated HL-60 cells showed an over-expression of TNF receptor-1 and death receptor-4 with associated caspase-8 activation, suggesting the activation of the extrinsic apoptotic pathway <ref type="bibr" target="#b37">[38]</ref>.</s><s>Our 24 h results showed that W RE increased PBMC caspase -8, -9 and -3/7 activities at different concentrations, suggesting the activation of extrinsic and intrinsic apoptotic pathways.</s><s>In the same time period, W RE increased THP-1 caspase -9 and -3/7 activities, suggesting initiation of apoptosis through the intrinsic pathway.</s><s>At 72 h, W RE (0.05-0.1 mg/ml) increased caspase (-8, -9, -3/7) activities, suggesting an increased initiation of PBMC apoptotic cell death.</s><s>However, 0.4 mg/ml W RE decreased initiator caspase (-8, -9) activities, suggesting a decreased initiation of PBMC apoptotic cell death.</s><s>In THP-1 cells, 0.1-0.2</s><s>mg/ml W RE (72 h) increased caspase (-8, -9, -3/7) activities, suggesting initiation of apoptosis through the intrinsic and extrinsic pathways.</s><s>However, at 0.05 and 0.4 mg/ml W RE (72 h), THP-1 caspase (-8, -9, -3/7) activities were decreased, suggesting a decrease in THP-1 apoptosis.</s><s>Previous studies have indicated that W. somnifera may activate the extrinsic and intrinsic apoptotic pathways <ref type="bibr" target="#b37">[38]</ref>, therefore our results prove to be consistent with other studies.</s></p><p><s>Increased caspase-3 activity, proteasome activity and E3 ubiquitin-conjugating enzyme expression is associated with increased proteolysis <ref type="bibr" target="#b50">[51]</ref>.</s><s>Therefore the ability of W RE (0.4 mg/ml, 72 h) to down regulate caspase activity in PBMC's and THP-1 cells may decrease proteolysis and the progression of cancer cachexia.</s></p><p><s>A successful anti-cancer drug should kill or incapacitate cancer cells without causing excessive damage to normal cells <ref type="bibr" target="#b38">[39]</ref>.</s><s>The potential of W RE to regulate PBMC apoptosis while increasing cancerous THP-1 cell apoptosis may be beneficial to cancer patients by preventing excessive cancerous cell growth while minimally effecting healthy PBMC's.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig. 1 Percentage DPPH scavenging activity of W RE (Values expressed as mean ± SD, * p &lt; 0.05, *** p &lt; 0.0001, compared to control)</s></p></div></figDesc><graphic coords="4,314.19,538.19,214.99,164.86" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2</head><label>2</label><figDesc><div><p><s>Fig. 2 Cell viability of PBMC's (a -24 h, b -72 h) and THP-1 (c -24 h, d -72 h) cells treated with W RE for 24 and 72 h (Values expressed as mean ± SD, * p &lt; 0.05, ** p &lt; 0.005, *** p &lt; 0.0001 compared to the control)</s></p></div></figDesc><graphic coords="5,127.28,94.85,340.76,285.05" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3</head><label>3</label><figDesc><div><p><s>Fig. 3 Concentration of TNF-α (a), IL-1β (b), IL-6 (c) and IL-10 (d) in LPS stimulated and W RE treated PBMC's (Values expressed as mean ± SD, * p &lt; 0.05, *** p &lt; 0.0001, compared to the control)</s></p></div></figDesc><graphic coords="6,127.28,94.85,340.76,283.98" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 4</head><label>4</label><figDesc><div><p><s>Fig. 4 Concentration of TNF-α (a), IL-1β (b), IL-6 (c) and IL-10 (d) in LPS stimulated and W RE treated THP-1 cells (Values expressed as mean ± SD, * p &lt; 0.05, *** p &lt; 0.0001 compared to the control)</s></p></div></figDesc><graphic coords="7,127.28,94.85,340.76,289.98" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Glutathione levels in LPS stimulated and W RE treated PBMC's and THP-1 cells</s></p></div></figDesc><table><row><cell>Glutathione (μM)</cell></row></table><note><p><s>(Values expressed as mean ± SD, *** p &lt; 0.0001, compared to the control)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Modulation of caspase (-8, -9, -3/7) activity and ATP levels in LPS stimulated and 24 h W RE treated PBMC's</s></p></div></figDesc><table><row><cell>W RE (mg/ml)</cell><cell>Caspase-8 (RLU × 10 5 )</cell><cell>Caspase-9 (RLU × 10 5 )</cell><cell>Caspase-3/7 (RLU × 10 5 )</cell><cell>ATP (RLU × 10 5 )</cell></row><row><cell>Control</cell><cell>0.185 ± 0.006</cell><cell>0.366 ± 0.0003</cell><cell>7.756 ± 0.006</cell><cell>4.714 ± 0.004</cell></row><row><cell>0.05</cell><cell>0.155 ± 0.0002 ***</cell><cell>0.376 ± 0.001 ***</cell><cell>8.109 ± 0.094 **</cell><cell>2.783 ± 0.017 ***</cell></row><row><cell>0.1</cell><cell>0.192 ± 0.00002</cell><cell>0.253 ± 0.0002 ***</cell><cell>11.504 ± 0.253 ***</cell><cell>5.208 ± 0.005 ***</cell></row><row><cell>0.2</cell><cell>0.246 ± 0.0003 ***</cell><cell>0.397 ± 0.0005 ***</cell><cell>8.961 ± 0.015 ***</cell><cell>3.741 ± 0.033 ***</cell></row><row><cell>0.4</cell><cell>4.814 ± 0.006 ***</cell><cell>0.351 ± 0.001 ***</cell><cell>17.095 ± 0.089 ***</cell><cell>6.965 ± 0.039 ***</cell></row><row><cell cols="3">(Values expressed as mean ± SD, ** p &lt; 0.005, *** p &lt; 0.0001 compared to the control)</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>Modulation of caspase (-8, -9, -3/7) activity and ATP levels in LPS stimulated and 24 h W RE treated THP-1 cells</s></p></div></figDesc><table><row><cell>W RE (mg/ml)</cell><cell>Caspase-8 (RLU × 10 5 )</cell><cell>Caspase-9 (RLU × 10 5 )</cell><cell>Caspase-3/7 (RLU × 10 5 )</cell><cell>ATP (RLU × 10 5 )</cell></row><row><cell>Control</cell><cell>10.207 ± 0.011</cell><cell>1.040 ± 0.007</cell><cell>1.251 ± 0.016</cell><cell>2.636 ± 0.011</cell></row><row><cell>0.05</cell><cell>8.440 ± 0.039 ***</cell><cell>2.365 ± 0.005 ***</cell><cell>1.315 ± 0.005 ***</cell><cell>3.726 ± 0.005 ***</cell></row><row><cell>0.1</cell><cell>2.413 ± 0.005 ***</cell><cell>2.459 ± 0.002 ***</cell><cell>2.294 ± 0.006 ***</cell><cell>5.132 ± 0.014 ***</cell></row><row><cell>0.2</cell><cell>7.149 ± 0.027 ***</cell><cell>0.775 ± 0.002 ***</cell><cell>3.406 ± 0.006 ***</cell><cell>29.838 ± 0.186 ***</cell></row><row><cell>0.4</cell><cell>2.456 ± 0.033 ***</cell><cell>3.197 ± 0.0001 ***</cell><cell>9.428 ± 0.004 ***</cell><cell>10.282 ± 0.195 ***</cell></row></table><note><p><s>(Values expressed as mean ± SD, *** p &lt; 0.0001 compared to the control)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 5</head><label>5</label><figDesc><div><p><s>Modulation of caspase (-8, -9, -3/7) activity and ATP levels in LPS-stimulated and 72 h W RE -treated THP-1 cells</s></p></div></figDesc><table><row><cell>W RE (mg/ml)</cell><cell>Caspase-8 (RLU × 10 5 )</cell><cell>Caspase-9 (RLU × 10 5 )</cell><cell>Caspase-3/7 (RLU × 10 5 )</cell><cell>ATP (RLU × 10 5 )</cell></row><row><cell>Control</cell><cell>0.991 ± 0.0001</cell><cell>5.738 ± 0.002</cell><cell>7.463 ± 0.012</cell><cell>4.332 ± 0.002</cell></row><row><cell>0.05</cell><cell>0.978 ± 0.0001 ***</cell><cell>5.562 ± 0.009 ***</cell><cell>6.919 ± 0.003 ***</cell><cell>4.133 ± 0.005 ***</cell></row><row><cell>0.1</cell><cell>1.216 ± 0.001 ***</cell><cell>7.045 ± 0.005 ***</cell><cell>8.211 ± 0.002 ***</cell><cell>4.889 ± 0.005 ***</cell></row><row><cell>0.2</cell><cell>1.095 ± 0.001 ***</cell><cell>6.091 ± 0.001 ***</cell><cell>7.532 ± 0.006 ***</cell><cell>4.576 ± 0.004 ***</cell></row><row><cell>0.4</cell><cell>0.952 ± 0.0003 ***</cell><cell>5.639 ± 0.003 ***</cell><cell>6.626 ± 0.007 ***</cell><cell>4.039 ± 0.0003 ***</cell></row></table><note><p><s>(Values expressed as mean ± SD, *** p &lt; 0.0001 compared to the control)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4</head><label>4</label><figDesc><div><p><s>Modulation of caspase (-8, -9, -3/7) activity and ATP levels in LPS stimulated and 72 h W RE treated PBMC's (Values expressed as mean ± SD, ** p &lt; 0.005, *** p &lt; 0.0001 compared to the control)</s></p></div></figDesc><table><row><cell>W RE (mg/ml)</cell><cell>Caspase-8 (RLU × 10 5 )</cell><cell>Caspase-9 (RLU × 10 5 )</cell><cell>Caspase-3/7 (RLU × 10 5 )</cell><cell>ATP (RLU × 10 5 )</cell></row><row><cell>Control</cell><cell>42.651 ± 0.039</cell><cell>115.041 ± 3.848</cell><cell>155.556 ± 0.387</cell><cell>20.574 ± 0.316</cell></row><row><cell>0.05</cell><cell>53.840 ± 0.026 ***</cell><cell>143.861 ± 3.929 ***</cell><cell>196.471 ± 0.338 ***</cell><cell>10.223 ± 0.046 ***</cell></row><row><cell>0.1</cell><cell>52.109 ± 0.009 ***</cell><cell>129.033 ± 0.289 ***</cell><cell>192.695 ± 0.233 ***</cell><cell>12.506 ± 0.373 ***</cell></row><row><cell>0.2</cell><cell>42.751 ± 0.039 **</cell><cell>105.494 ± 4.247 **</cell><cell>154.203 ± 0.224 ***</cell><cell>13.210 ± 0.043 ***</cell></row><row><cell>0.4</cell><cell>29.656 ± 0.007 ***</cell><cell>92.718 ± 0.021 ***</cell><cell>165.139 ± 0.096 ***</cell><cell>13.361 ± 0.279 ***</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We are grateful to the National Research Foundation, the South African Medical Research Council, Department of Science and Technology, Government of India and Manipal University for financial support to conduct experimentation.</s><s>The authors also acknowledge Miss Tarylee Reddy for assistance with statistical analysis of data.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>The syndrome decreases the quality of life of patients, the responsiveness to chemotherapy and leads to 20-25% of cancer deaths <ref type="bibr" target="#b2">[3]</ref>.</s><s>Our results show that W RE increased oxidant scavenging activity, modulated GSH and pro-inflammatory cytokine levels and regulated caspase activity in normal PBMC's and THP-1 cells.</s><s>The discovery of a medicinal plant capable of decreasing the levels of pro-inflammatory cytokines may decrease tissue wasting.</s><s>In this study, the root extract of W. somnifera has shown promising results in modulating the production of cytokines associated with cancer cachexia.</s><s>The ability of W RE to decrease pro-inflammatory cytokine levels and increase cancerous cell death may decrease the development and progression of cancer and cachexia.</s><s>W RE may therefore be effective in cancer cachexia.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional file</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>All data generated or analysed during this study are included in this published article as a Additional file 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' contributions</head><p><s>DBN carried out all experimentation except the luminometry (Caspase, ATP, GSH) assays.</s><s>DBN analysed and interpreted data, performed statistical analysis, drafted and revised the manuscript.</s><s>AC and AP carried out luminometry assays and provided intellectual input into the manuscript.</s><s>VS, KPG and KS gave substantial contributions to conception, design and supervision of the study and revision of the manuscript.</s><s>All authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate</head><p><s>Collection of PBMC's was approved by the Ethics Committee of the South African Medical Research Council (EC09-018) and the South African National Blood Service (2011/09).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication</head><p><s>Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>The author(s) declare that they have no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publisher's Note</head><p><s>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Chronic inflammation and cytokines in the tumor microenvironment</title>
		<author>
			<persName><forename type="first">G</forename><surname>Landskron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De La Fuente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Thuwajit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thuwajit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hermoso</surname></persName>
		</author>
		<idno type="DOI">10.1155/2014/149185</idno>
		<ptr target="https://doi.org/10.1155/2014/149185" />
	</analytic>
	<monogr>
		<title level="j">J Immunol Res</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A cytokine-mediated link between innate immunity, inflammation, and cancer</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1175" to="1183" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Mechanisms of cancer cachexia</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Tisdale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="381" to="410" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Loss of skeletal muscle in cancer: biochemical mechanisms</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Tisdale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Biosci</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="D164" to="D174" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Cancer anorexia-cachexia syndrome: current issues in research and management</title>
		<author>
			<persName><forename type="first">A</forename><surname>Inui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="72" to="91" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Reduced plasma lipoprotien lipase activity in patients with malignancy-associated weight loss</title>
		<author>
			<persName><forename type="first">H</forename><surname>Vlassara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Speigel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">San</forename><surname>Doval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cerami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="698" to="703" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Sequential changes in the activities of lipoprotien lipase and lipogenic enzymes during tumor growth in rats</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lanza-Jacoby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Lansey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Cleary</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="5062" to="5067" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Parry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tuckey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1180</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="236" to="242" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lundholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bennegard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Eden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Svaninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Emery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rennie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="4807" to="4811" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Skeletal muscle metabolism in patients with malignant tumour</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lundholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Bylund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Holm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Scherstén</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="465" to="473" />
			<date type="published" when="1976">1976</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Muscle protein breakdown and critical role of the ubiquitin-proteasome pathway in normal and disease states</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Mitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Goldberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="227" to="237" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Hormonal changes and catabolic / anabolic imbalance in chronic heart failure and their importance for cardiac cachexia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Chua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ponikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Swan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Kox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="526" to="534" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Insights into the pathogenesis of chronic heart failure: immune activation and cachexia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rauchhaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Cardiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="211" to="216" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">B</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Wewers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="3820" to="3826" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Interleukin-6: an overview</title>
		<author>
			<persName><forename type="first">J</forename><surname>Van Snick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="253" to="278" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Toll-like receptor signaling</title>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">40</biblScope>
			<biblScope unit="page" from="38105" to="38108" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Janssen-Heininger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Poynter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Baeuerle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Free Radic Biol Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1317" to="1327" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappaB</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Bae</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="3589" to="3593" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Involvement of reactive oxygen species in toll-like receptor 4-dependent activation of NFkappa B</title>
		<author>
			<persName><forename type="first">K</forename><surname>Asehnoune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Strassheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mitra</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Abraham</forename><forename type="middle">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="2522" to="2529" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Regulation of lipoprotien lipase mRNA content in 3T3-L1 cells by tumour necrosis factor</title>
		<author>
			<persName><forename type="first">P</forename><surname>Cornelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Enerback</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bjursell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Olivecrona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Pekala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">249</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="765" to="769" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia</title>
		<author>
			<persName><surname>Jm A'e</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Busquets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Felipe</forename><forename type="middle">A</forename><surname>Fj L'o-S</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Biochem Cell Biol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1084" to="1104" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Interleukin 6 reduces lipoprotien lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Nordan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcintosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Calvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Scow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jablons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="4113" to="4116" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Beutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cerami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="3969" to="3971" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Tumour necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins</title>
		<author>
			<persName><forename type="first">C</forename><surname>Garcia-Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Agell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Llovera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>López-Soriano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Argilés</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="211" to="214" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Ubiquitin gene expession in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1</title>
		<author>
			<persName><forename type="first">C</forename><surname>Garcia-Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Llovera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Agell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>López-Soriano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Argilés</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Comm</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="839" to="844" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ebisui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsujinaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Morimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Iijima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Sci</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="431" to="439" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Grivennikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Greten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity, inflammation, and Cancer. Cell</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="883" to="899" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants</title>
		<author>
			<persName><forename type="first">M</forename><surname>Buck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chojkier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1753" to="1765" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Apoptosis: a review of programmed cell death</title>
		<author>
			<persName><forename type="first">S</forename><surname>Elmore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicol Pathol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="495" to="516" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions</title>
		<author>
			<persName><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Miereles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Debigare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="115" to="123" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Biological activities of Withania somnifera</title>
		<author>
			<persName><forename type="first">G</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dudhe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Biol Res</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="56" to="63" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Biological activity of withanolides</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Budhiraja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Krishan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sudhir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Sci Ind Res</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="904" to="911" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">A standardized root extract of Withania somnifera and its major constituent withanolide-a elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice</title>
		<author>
			<persName><forename type="first">F</forename><surname>Malik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Khajuria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Suri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Satti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Life Sci</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="1525" to="1538" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Pharmacological studies on leaves of Withania somnifera</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sudhir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Budhiraja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Miglani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Arora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Garg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Planta Med</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="61" to="63" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Major medicinal plants of India. New Delhi: central Institute of Medicinal and Aromatic</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Thakur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Puri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Husain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Plants</title>
		<imprint>
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Diwanay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Patki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Patwardhan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Ethnopharmacol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="35" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Response of a mouse fibrosarcoma to withferin a and radiation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kamath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Satish</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Uma</forename><surname>Devi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharm Pharmacol Commun</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="287" to="291" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Immune modulation and apoptosis induction: two sides of antitumoural activity of a standardized herbal formulation of Withania somnifera</title>
		<author>
			<persName><forename type="first">F</forename><surname>Malik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bhushan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Mondhe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Pal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sharma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1494" to="1509" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">A review on traditional medicinal plants for anticancerous activity</title>
		<author>
			<persName><forename type="first">Jcj</forename><surname>Rosario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Josephine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Recent Sci Res</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="5634" to="5637" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main">Medicinal plants of South Africa</title>
		<author>
			<persName><forename type="first">B-E</forename><surname>Van Wyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Van Oudshoorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gericke</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
			<publisher>Briza Publications</publisher>
			<pubPlace>Pretoria</pubPlace>
		</imprint>
	</monogr>
	<note>2nd ed</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Modulating effect of Withania somnifera on TCA cycle enzymes and electron transport chain in azoxymethane-induced colon cancer in mice</title>
		<author>
			<persName><forename type="first">G</forename><surname>Muralikrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Amanullah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Basha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Dinda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Shakeel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunopharmacol Immunotoxicol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="523" to="527" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Caspase functions in cell death and disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Mcilwain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Mak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cold Spring Harb Perspect Biol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1" to="28" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: an in vivo and in vitro study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rasool</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Varalakshmi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vasc Pharmacol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="406" to="410" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Effect of extraction methods on yield, phytochemical constituents and antioxidant activity of Withania somnifera</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dhanani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Gajbhiye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arab J Chem</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="S1193" to="S1199" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Effect of some Indian herbs on macrophage functions in ochratoxin a treated mice</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Dhuley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Ethnopharmacol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="15" to="20" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Recombinant human cachectin/tumor necrosis factor but not interleukin-1 alpha downregulates lipoprotien lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zechner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sherry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cerami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Breslow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2394" to="2401" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles</title>
		<author>
			<persName><forename type="first">M</forename><surname>Llovera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Garcia-Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Agell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>López-Soriano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Argilés</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">230</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="238" to="241" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Mechanism of induction of muscle protein loss by hyperglycaemia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rajani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Dhadda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Tisdale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="16" to="25" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Guttridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Mayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Madrid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Asj</forename><surname>Baldwin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="issue">5488</biblScope>
			<biblScope unit="page" from="2363" to="2366" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Free radicals, antioxidants, and nutrition</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Z</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutrition</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="872" to="879" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Mitch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="4160" to="4168" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
